Forbes published an article which talks about a new study found in the journal Cell Host & Microbe and offers some clues as to why sometimes the body doesn’t seem
OptiBiotix Health plc (AIM: OPTI), a life sciences business developing compounds to tackle obesity, high cholesterol, diabetes and skin care, has told DirectorsTalk about the departure of Jim Laird by mutual agreement and the appointment of Per Rehné as Commercial Director. Per will join the
OptiBiotix Health’s Stephen O’Hara discusses their joint product agreement with a multinational and other potential commercial progress in this exclusive interview with DirectorsTalk
OptiBiotix Health plc (LON:OPTI), a life sciences business developing products to tackle obesity, high cholesterol and diabetes, announces that it has entered into a joint development agreement (the “Agreement”) with
OptiBiotix Health plc (AIM: OPTI), a life sciences business developing products to tackle obesity, high cholesterol and diabetes, has told DirectorsTalk that it has entered into a joint development agreement
Stephen O’Hara, CEO of OptiBiotix LON:OPTI, commented: “The Company believes it is making strong scientific progress across all its technology and product platforms. These research findings add to the growing scientific
Optibiotix Health Plc (LON:OPTI) CEO Stephen OHara today spoke about an article published in the telegraph. The article refers to a major Lancet study which backed the safety of statins
Topping the 11th annual list of Cleveland Clinic’s ‘Top 10 Medical Innovations’ is the harnessing of the microbiome, the gut bacteria swarming in all of us. Recent discoveries have revealed
OptiBiotix Health’s Stephen O’Hara discusses their recent scientific and commercial update in this exclusive interview with DirectorsTalk
OptiBiotix Health plc (AIM: OPTI), a life sciences business developing compounds to tackle obesity, high cholesterol, diabetes and skin care, has told DirectorsTalk that it is presenting at the European Edition of the Microbiome Summit 2016 in London. The conference will
© 2025 – DirectorsTalk. All rights reserved. Reproduction in whole or in part, in any form or medium without express written permission is prohibited.
